Arteris, Inc. (NASDAQ:AIP) VP Paul L. Alpern Sells 3,609 Shares

Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul L. Alpern sold 3,609 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $6.03, for a total transaction of $21,762.27. Following the completion of the sale, the vice president now directly owns 83,717 shares in the company, valued at $504,813.51. This represents a 4.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Arteris Trading Up 5.2 %

Shares of AIP stock traded up $0.29 during mid-day trading on Wednesday, reaching $5.88. The company's stock had a trading volume of 45,555 shares, compared to its average volume of 253,211. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $240.77 million, a PE ratio of -6.76 and a beta of 1.31. The company's 50 day simple moving average is $8.40 and its 200-day simple moving average is $8.76. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $12.64.

Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.08). Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. The company had revenue of $15.49 million for the quarter, compared to analyst estimates of $15.34 million. On average, research analysts predict that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Rosenblatt Securities reissued a "buy" rating and set a $15.00 price objective on shares of Arteris in a research note on Tuesday, February 18th. Northland Securities upped their price target on Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 19th.

Institutional Trading of Arteris

Several large investors have recently bought and sold shares of AIP. US Bancorp DE grew its holdings in Arteris by 29.0% during the 4th quarter. US Bancorp DE now owns 5,702 shares of the company's stock valued at $58,000 after purchasing an additional 1,283 shares in the last quarter. American Century Companies Inc. grew its stake in shares of Arteris by 6.0% during the fourth quarter. American Century Companies Inc. now owns 30,357 shares of the company's stock valued at $309,000 after acquiring an additional 1,731 shares in the last quarter. EntryPoint Capital LLC grew its stake in shares of Arteris by 14.0% during the fourth quarter. EntryPoint Capital LLC now owns 19,814 shares of the company's stock valued at $202,000 after acquiring an additional 2,430 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Arteris by 4.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 78,690 shares of the company's stock worth $802,000 after acquiring an additional 3,298 shares during the last quarter. Finally, Wells Fargo & Company MN lifted its stake in shares of Arteris by 38.9% in the fourth quarter. Wells Fargo & Company MN now owns 13,192 shares of the company's stock worth $134,000 after acquiring an additional 3,694 shares in the last quarter. Institutional investors and hedge funds own 64.36% of the company's stock.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.